T-705 (favipiravir) inhibition of arenavirus replication in cell culture

Michelle Mendenhall, Andrew Russell, Terry Juelich, Emily L. Messina, Donald F. Smee, Alexander N. Freiberg, Michael R. Holbrook, Yousuke Furuta, Juan Carlos De La Torre, Jack H. Nunberg, Brian B. Gowen

Research output: Contribution to journalArticle

58 Scopus citations

Abstract

A number of New World arenaviruses (Junín [JUNV], Machupo [MACV], and Guanarito [GTOV] viruses) can cause human disease ranging from mild febrile illness to a severe and often fatal hemorrhagic fever syndrome. These highly pathogenic viruses and the Old World Lassa fever virus pose a significant threat to public health and national security. The only licensed antiviral agent with activity against these viruses, ribavirin, has had mixed success in treating severe arenaviral disease and is associated with significant toxicities. A novel pyrazine derivative currently in clinical trials for the treatment of influenza virus infections, T-705 (favipiravir), has demonstrated broad-spectrum activity against a number of RNA viruses, including arenaviruses. T-705 has also been shown to be effective against Pichinde arenavirus infection in a hamster model. Here, we demonstrate the robust antiviral activity of T-705 against authentic highly pathogenic arenaviruses in cell culture. We show that T-705 disrupts an early or intermediate stage in viral replication, distinct from absorption or release, and that its antiviral activity in cell culture is reversed by the addition of purine bases and nucleosides, but not with pyrimidines. Specific inhibition of viral replication/transcription by T-705 was demonstrated using a lymphocytic choriomeningitis arenavirus replicon system. Our findings indicate that T-705 acts to inhibit arenavirus replication/transcription and may directly target the viral RNA-dependent RNA polymerase.

Original languageEnglish (US)
Pages (from-to)782-787
Number of pages6
JournalAntimicrobial Agents and Chemotherapy
Volume55
Issue number2
DOIs
StatePublished - Feb 1 2011

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'T-705 (favipiravir) inhibition of arenavirus replication in cell culture'. Together they form a unique fingerprint.

  • Cite this

    Mendenhall, M., Russell, A., Juelich, T., Messina, E. L., Smee, D. F., Freiberg, A. N., Holbrook, M. R., Furuta, Y., De La Torre, J. C., Nunberg, J. H., & Gowen, B. B. (2011). T-705 (favipiravir) inhibition of arenavirus replication in cell culture. Antimicrobial Agents and Chemotherapy, 55(2), 782-787. https://doi.org/10.1128/AAC.01219-10